COMMUNIQUÉS West-GlobeNewswire

Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy
16/05/2025
TEL AVIV, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals (NYSE and TASE: TEVA) today announced that Moody's Investor Services (“Moody's”) has raised the company's corporate credit rating to Ba1, outlook [...]
HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results
16/05/2025
MIRAMAR, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel [...]
FuturHealth Under Review: Best GLP-1 Semaglutide Medication Prescription for Weight Loss with No Insurance
16/05/2025
Discover How FuturHealth’s Affordable Semaglutide Subscription Program Helps Users Lose Weight Without Insurance, Prescriptions, or Hassle—A Game-Changer in the GLP-1 Weight Loss Revolution San Diego, May 15, 2025 ( [...]
Ancient Biblical Remedies Under Review: Ancient Lost Remedies Revived with Hidden Healing Secret Remedies of the Scriptures
16/05/2025
365 Daily Health Unveils “The Encyclopedia of Natural Remedies” — A Faith-Based Digital Guide Reviving Ancient Biblical Remedies with Over 100 Scripture-Inspired Healing Practices for Holistic Wellness, Spiritual [...]
Biofrontera Inc. Announces New Patent Protection on Ameluz® until 2043 and the Completion of Patient Enrollment in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris
15/05/2025
Biofrontera has received patent approval for the revised formulation of Ameluz ® , which extends patent protection through to December 2043 Ameluz PDT offers the potential for effective treatment of moderate to severe [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Avril 2025
15/05/2025
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Sanofi: Information concerning the total number of voting rights and shares - April 2025
15/05/2025
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Regeneron Prevails over Amgen in Antitrust PCSK9 Lawsuit Protecting Biotech Innovation and Patient Access to Life-Saving Treatments
15/05/2025
Federal court jury found Amgen liable for violating antitrust and tort laws by using cross-therapeutic bundled rebates to prevent Praluent ® (alirocumab) from competing in the market Jury awarded Regeneron $135.6 [...]
Arialief Criticism Reviewed: The Tainted Neuropathy Relief Controversy Published
15/05/2025
Unmasking the Truth About Arialief: Honest Reviews, Ingredient Warnings, and the Real Reasons Behind User Complaints In This Arialief Review, You’ll Discover: What Arialief is and how Arialief is marketed as a top [...]
RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven
15/05/2025
CHICAGO, May 15, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of [...]
Philips successfully prices offering of Notes for EUR 1 billion to be used for repayment of existing debt and to finance eligible green projects
15/05/2025
May 15, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 500 million fixed rate notes due 2030 [...]
Global Medtech Outsourcing Market Grows to $89B in 2024 as CDMOs Emerge as Strategic Partners, Finds Alira Health
15/05/2025
Fifth annual report reveals growing OEM reliance on CDMOs, M&A momentum, and innovation in polymers and orthopedics FRAMINGHAM, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Alira Health, a global healthcare consulting [...]
OmniMD Announces AI Clinicians: Ushering in a New Era of Predictive, Personalized, and Effortless Healthcare Delivery
15/05/2025
OmniMD unveils AI Clinicians; a bold leap into the future of healthcare. Designed to think like a physician and act faster than one, AI Clinicians combine clinical intelligence, predictive analytics, and real-time [...]
Connect Biopharma Reports First Quarter 2025 Financial Results and Provides Business Update
15/05/2025
Initiated Phase 2 Seabreeze STAT Asthma and Seabreeze STAT COPD studies evaluating rademikibart as an adjunct treatment for acute exacerbations in Asthma and COPD in May 2025; topline data expected in 1H 2026 Published [...]
GT Biopharma Appoints New Member to its Board of Directors
15/05/2025
SAN FRANCISCO, CALIFORNIA, May 15, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company' [...]
Lipella Pharmaceuticals to Present Phase 2a Data for LP-310 in Oral Lichen Planus at 2025 AAOM/EAOM International Meeting
15/05/2025
Statistically significant safety and efficacy data from 0.25 mg and 0.50 mg cohorts to be presented Presentation scheduled for Thursday, May 15, 2025, at 11:36 a.m. PT PITTSBURGH, May 15, 2025 (GLOBE NEWSWIRE) -- [...]
Intelligent Bio Solutions Accelerates Global Adoption of Fingerprint Drug Testing
15/05/2025
Company surpasses 450 accounts across 24 countries as global demand for fingerprint drug testing surges NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company [...]
Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025
15/05/2025
SAN DIEGO and LONDON and DUBLIN and SYDNEY, May 15, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, has been [...]
PharmAla Biotech Launches Phenesafe AI Drug Discovery Platform for Novel Phenethylamines
15/05/2025
TORONTO, May 15, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]

Pages